ATE5070T1 - Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung. - Google Patents

Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung.

Info

Publication number
ATE5070T1
ATE5070T1 AT79102616T AT79102616T ATE5070T1 AT E5070 T1 ATE5070 T1 AT E5070T1 AT 79102616 T AT79102616 T AT 79102616T AT 79102616 T AT79102616 T AT 79102616T AT E5070 T1 ATE5070 T1 AT E5070T1
Authority
AT
Austria
Prior art keywords
formula
esters
preference
alkyl
compounds
Prior art date
Application number
AT79102616T
Other languages
English (en)
Inventor
Donald W. Graham
Frederick M. Kahan
Edward F. Rogers
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE5070(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE5070T1 publication Critical patent/ATE5070T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Eye Examination Apparatus (AREA)
  • Detergent Compositions (AREA)
AT79102616T 1978-07-24 1979-07-24 Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung. ATE5070T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92721278A 1978-07-24 1978-07-24
US5023379A 1979-06-22 1979-06-22

Publications (1)

Publication Number Publication Date
ATE5070T1 true ATE5070T1 (de) 1983-11-15

Family

ID=26728044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79102616T ATE5070T1 (de) 1978-07-24 1979-07-24 Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung.

Country Status (28)

Country Link
EP (1) EP0010573B1 (de)
JP (1) JPS63295540A (de)
KR (1) KR850000425B1 (de)
AT (1) ATE5070T1 (de)
AU (1) AU527772B2 (de)
BG (1) BG60346B2 (de)
CA (1) CA1161058A (de)
CZ (1) CZ280564B6 (de)
DE (1) DE2966328D1 (de)
DK (1) DK157399C (de)
EG (1) EG13961A (de)
ES (2) ES482773A1 (de)
FI (1) FI76069C (de)
GR (1) GR70699B (de)
HK (1) HK5085A (de)
HU (1) HU182531B (de)
IE (1) IE49182B1 (de)
IL (1) IL57797A (de)
MA (1) MA18534A1 (de)
NZ (1) NZ190994A (de)
PH (1) PH16708A (de)
PL (2) PL125506B1 (de)
PT (1) PT69954B (de)
RO (2) RO78106A (de)
SG (1) SG65484G (de)
SU (1) SU1213983A3 (de)
YU (2) YU43455B (de)
ZW (1) ZW13379A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
EP0048025B1 (de) * 1980-09-17 1986-01-15 Merck & Co. Inc. Antibakterielle Zusammensetzung einer Verbindung der Thienamycin-Gattung und eines Dipeptidase Inhibitors
PT73640B (en) * 1980-09-17 1983-10-19 Merck & Co Inc Process for preparing chemical compounds selectively inhibit the metabolism of dipeptidase
JPS58170479A (ja) * 1982-03-30 1983-10-07 Sanraku Inc ジペプチダ−ゼ阻害剤
JPS58174345A (ja) * 1982-04-06 1983-10-13 Sumitomo Chem Co Ltd 光学活性２，２−ジメチルシクロプロパン−１−カルボン酸ハライドのラセミ化方法
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
DE3508564A1 (de) * 1985-03-11 1986-09-11 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von n-acyl-2, 3-dehydroaminocarbonsaeureestern
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
CA2052730A1 (en) 1990-10-11 1992-04-12 Frank P. Dininno 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
ATE217195T1 (de) * 1991-02-01 2002-05-15 Suntory Ltd Verwendung von cilastatin, glutathione und n- acetyl-l-cysteine zur herstellung eines arzneimittels zur verbesserung der resorption von carbapenem oder penem antibiotika im magen-darm- trakt
CN103502411B (zh) 2011-04-28 2016-01-20 味之素株式会社 液体洗涤剂组合物
PL442220A1 (pl) 2022-09-07 2024-03-11 Politechnika Wrocławska Sposób i układ do wytwarzania nawozu mikroelementowego

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2449191A (en) * 1945-08-24 1948-09-14 Lilly Co Eli Phenacetylaminomethylcrotonic acid
US2569801A (en) * 1947-02-12 1951-10-02 American Cyanamid Co Preparation of azlactones of phenylacetamino acrylic acids
US2622074A (en) 1949-12-09 1952-12-16 Eastman Kodak Co Salts of alpha-acylamido and alpha-alkoxycarbonamido acrylic acids
BE664781A (de) 1964-06-01
GB1260847A (en) 1968-12-06 1972-01-19 Nat Res Dev Esters of cyclopropane carboxylic acids
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
DK143713C (da) 1975-11-21 1982-03-08 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof n-acetyl-thienamycin og salte deraf
CS226166B2 (cs) 1975-11-21 1984-03-19 Merck & Co Inc Způsob přípravy derivátů thienamycinu
DK143712C (da) 1975-11-21 1982-03-22 Merck & Co Inc Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3
DK497476A (da) 1975-11-24 1977-05-25 Merck & Co Inc Fremgangsmade til fremstilling af et antibiotisk stof
US4070477A (en) 1975-12-08 1978-01-24 Ciba-Geigy Corporation 2-Penem compounds
DK487877A (da) 1976-11-17 1978-05-18 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof
NL7712092A (nl) 1976-11-17 1978-05-19 Merck & Co Inc Werkwijze ter bereiding van een nieuw antibiotisch middel.
GB1593524A (en) 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE7800978L (sv) 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
SE7800979L (sv) 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
JPS604719B2 (ja) 1977-03-31 1985-02-06 メルシャン株式会社 β‐ラクタマーゼ阻害活性を有する抗生物質ＰＳ―５の製造方法
US4162323A (en) 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
BE867227A (fr) 1977-10-31 1978-11-20 Merck & Co Inc Preparation de l'acide 6-(alpha-hydroxyethyl)-7-oxo-1-azabicyclo (3,2,0) hept-2-ene-carboxylique et derives a activite antibiotique

Also Published As

Publication number Publication date
PL131618B1 (en) 1984-12-31
IE49182B1 (en) 1985-08-21
CZ280564B6 (cs) 1996-02-14
HK5085A (en) 1985-01-25
ZW13379A1 (en) 1981-05-06
ES492553A0 (es) 1981-07-16
FI76069C (fi) 1988-09-09
NZ190994A (en) 1981-10-19
DK157399B (da) 1990-01-02
FI792281A (fi) 1980-01-25
HU182531B (en) 1984-02-28
PH16708A (en) 1984-01-20
SU1213983A3 (ru) 1986-02-23
DK157399C (da) 1990-05-21
KR830001188A (ko) 1983-04-29
PL217327A1 (de) 1980-12-01
AU4893379A (en) 1980-01-31
PT69954A (en) 1979-08-01
CZ513679A3 (en) 1995-09-13
RO83292A (ro) 1984-02-21
BG60346B2 (bg) 1994-09-30
RO83292B (ro) 1984-02-28
IE791387L (en) 1980-01-24
YU43455B (en) 1989-08-31
EP0010573A1 (de) 1980-05-14
PL225939A1 (de) 1981-10-02
GR70699B (de) 1982-12-30
SG65484G (en) 1985-03-29
ES8106132A1 (es) 1981-07-16
FI76069B (fi) 1988-05-31
EP0010573B1 (de) 1983-10-19
PT69954B (pt) 1981-06-11
AU527772B2 (en) 1983-03-24
RO78106A (ro) 1982-04-12
ES482773A1 (es) 1980-09-01
KR850000425B1 (ko) 1985-04-03
YU178879A (en) 1983-04-30
IL57797A (en) 1986-01-31
IL57797A0 (en) 1979-11-30
CA1161058A (en) 1984-01-24
YU43144B (en) 1989-04-30
DK309879A (da) 1980-02-28
JPH0440338B2 (de) 1992-07-02
PL125506B1 (en) 1983-05-31
JPS63295540A (ja) 1988-12-01
EG13961A (en) 1983-03-31
MA18534A1 (fr) 1980-04-01
DE2966328D1 (en) 1983-11-24
YU10183A (en) 1983-04-30

Similar Documents

Publication Publication Date Title
HUT65593A (en) Process for producing ester derivatives of hexahidro naphthaline and pharmaceutical compositions containing them
ATE5070T1 (de) Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung.
ATE56963T1 (de) Verfahren zur herstellung von aminothiazolessigsaeurederivaten.
ES2023157B3 (es) Procedimiento para obtener acido tetrafluoroftalico.
EP0802179A4 (de) Derivate substituierter amidinonaphthylester
HUT46701A (en) Process for producing alpha-amino-alkyl-phosphonic acids
RO84705A (ro) Procedeu pentru prepararea benzatiazincarbo0amidelor
ES2019551A6 (es) Procedimiento para la obtencion de derivados del acido 6-fluor-1, 4-dihidro-4-oxo-7-piperacinil-3-quinlincarboxilico.
MY105176A (en) Process for optically active 3-thiolanyl sulfonate esters.
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification